3M
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-22 12:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 8-K | 2026-11-04 | Read on SEC.gov |
| 10-Q | 2026-10-20 | Read on SEC.gov |
| 8-K | 2026-10-20 | Read on SEC.gov |
| 8-K | 2026-10-19 | Read on SEC.gov |
| 8-K | 2026-09-10 | Read on SEC.gov |
| 8-K | 2026-08-19 | Read on SEC.gov |
| 10-Q | 2026-07-21 | Read on SEC.gov |
| 8-K | 2026-07-21 | Read on SEC.gov |
SEC annual financial snapshot
Standard US-GAAP facts in 10-K filings, USD. Income and cash flow cover the annual period; balance-sheet amounts are as of period end. These are not quarterly or TTM figures. Latest available filed values may include restatements; reporting periods can differ from other providers. Checked: 2026-11-22 09:51 UTC.
| Metric | USD | Basis | Period end | Filed | Source |
|---|---|---|---|---|---|
| Revenue | $24.95B | Annual | 2025-12-31 | 2026-02-03 | 10-K |
| Net income | $3.25B | Annual | 2025-12-31 | 2026-02-03 | 10-K |
| Operating cash flow | $2.31B | Annual | 2025-12-31 | 2026-02-03 | 10-K |
| Total assets | $37.73B | As of | 2025-12-31 | 2026-02-03 | 10-K |
| Total liabilities | $32.99B | As of | 2025-12-31 | 2026-02-03 | 10-K |
| Stockholders’ equity | $4.70B | As of | 2025-12-31 | 2026-02-03 | 10-K |
✦ Quant Financial Health how this is computed
- Altman Z-Score is 4.39, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
✦ Quant Revenue Concentration how this is computed
- Safety and Industrial is the largest reported line at 48.33% of revenue, across 4 reported segments.
- Transportation and Electronics follows at 30.36%, so the top line still matters most but isn’t the whole story.
Revenue annual, last 8 years
Latest year +1.52% YoY
Margins
- Gross margin
- 39.91%
- Operating margin
- 19.20%
- Net margin
- 13.03%
Key ratios & quality
- Enterprise valuei
- 98.64B
- Altman Z-Scorei
- 4.39
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 32.77B | 32.14B | 32.18B | 35.36B | 26.16B | 24.61B | 24.58B | 24.95B |
| Gross profit | 16.08B | 15.00B | 15.58B | 16.56B | 10.31B | 9.63B | 10.13B | 9.96B |
| Selling & admin expenses | 7.60B | 7.03B | 6.93B | 7.20B | 7.23B | 19.20B | 4.22B | 4.00B |
| Research & development | 1.82B | 1.91B | 1.88B | 1.99B | 1.16B | 1.15B | 1.09B | 1.17B |
| Operating profit | 6.66B | 6.06B | 6.77B | 7.37B | 1.92B | -10.73B | 4.82B | 4.79B |
| Pretax profit | 7.00B | 5.64B | 6.80B | 7.20B | 4.20B | -11.27B | 4.82B | 4.21B |
| Tax | 1.64B | 1.11B | 1.34B | 1.29B | 188.00M | -2.87B | 804.00M | 1.00B |
| Net profit | 5.36B | 4.53B | 5.45B | 5.93B | 5.79B | -6.98B | 4.19B | 3.26B |
| Basic EPS | 9 | 8 | 9 | 10 | 10 | -13 | 8 | 6 |
| Diluted EPS | 8.89 | 7.72 | 9.36 | 10.12 | 10.18 | -12.63 | 7.55 | 6.00 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 6.34B | 6.52B | 6.13B | 6.03B | 6.50B | 6.58B |
| Gross profit | 2.70B | 2.73B | 2.06B | 2.46B | 2.68B | 2.78B |
| Selling & admin expenses | 1.27B | 820.00M | 965.00M | 744.00M | 1.06B | 921.00M |
| Research & development | 288.00M | 297.00M | 299.00M | 308.00M | 302.00M | 304.00M |
| Operating profit | 1.14B | 1.61B | 794.00M | 1.40B | 1.32B | 1.56B |
| Pretax profit | 923.00M | 1.15B | 758.00M | 878.00M | 1.12B | 1.67B |
| Tax | 245.00M | 308.00M | 185.00M | 221.00M | 183.00M | 261.00M |
| Net profit | 725.00M | 841.00M | 574.00M | 659.00M | 938.00M | 1.41B |
| Basic EPS | 1 | 2 | 1 | 1 | 2 | 3 |
| Diluted EPS | 1.34 | 1.55 | 1.07 | 1.23 | 1.78 | 2.63 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 13.71B | 12.97B | 14.98B | 15.40B | 14.69B | 16.38B | 15.88B | 16.39B |
| Cash & ST investments | 3.23B | 2.45B | 5.04B | 4.77B | 3.89B | 5.79B | 7.73B | 5.93B |
| Inventory | 4.37B | 4.13B | 4.24B | 4.99B | 5.37B | 3.94B | 3.70B | 3.66B |
| Total assets | 36.50B | 44.66B | 47.34B | 47.07B | 46.46B | 50.58B | 39.87B | 37.73B |
| Total current liabilities | 7.24B | 9.22B | 7.95B | 9.04B | 9.52B | 15.30B | 11.26B | 9.60B |
| Short-term debt | 1.21B | 3.04B | 1.06B | 1.57B | 2.20B | 3.14B | 1.92B | 1.67B |
| Long-term debt | 13.41B | 17.52B | 17.99B | 16.06B | 14.00B | 13.09B | 11.13B | 10.93B |
| Total liabilities | 26,652,000,000.00 | 34,533,000,000.00 | 34,413,000,000.00 | 31,955,000,000.00 | 31,685,000,000.00 | 45,712,000,000.00 | 35,974,000,000.00 | 32,986,000,000.00 |
| Total equity | 9.85B | 10.13B | 12.93B | 15.12B | 14.77B | 4.87B | 3.89B | 4.75B |
| Retained earnings | 40.64B | 42.14B | 43.82B | 45.82B | 47.95B | 37.48B | 36.80B | 38.26B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 13.43B | 16.09B | 16.39B | 14.39B | 14.11B | 16.71B |
| Cash & ST investments | 4.21B | 5.19B | 5.93B | 4.15B | 3.33B | 5.15B |
| Inventory | 4.08B | 3.89B | 3.66B | 3.69B | 3.77B | 4.08B |
| Total assets | 37.99B | 37.61B | 37.73B | 35.44B | 34.92B | 39.53B |
| Total current liabilities | 7.81B | 8.73B | 9.60B | 9.03B | 11.38B | 11.87B |
| Short-term debt | 849.00M | 923.00M | 1.67B | 1.65B | 1.65B | 2.44B |
| Long-term debt | 12.48B | 11.85B | 10.93B | 10.91B | 10.90B | 12.56B |
| Total liabilities | 33,638,000,000.00 | 32,936,000,000.00 | 32,986,000,000.00 | 32,125,000,000.00 | 31,919,000,000.00 | 34,386,000,000.00 |
| Total equity | 4.35B | 4.68B | 4.75B | 3.31B | 3.01B | 5.14B |
| Retained earnings | 37.69B | 38.10B | 38.26B | 38.16B | 38.63B | 39.59B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 6.44B | 7.07B | 8.11B | 7.45B | 5.59B | 6.68B | 1.82B | 2.31B |
| Depreciation & amortization | 1.49B | 1.59B | 1.91B | 1.92B | 1.83B | 1.99B | 1.36B | 1.31B |
| Free cash flow | 4.86B | 5.37B | 6.61B | 5.85B | 3.84B | 5.07B | 638.00M | 1.40B |
| Dividends paid | -3.19B | -3.32B | -3.39B | -3.42B | -3.37B | -3.31B | -1.98B | -1.56B |
| Stock buybacks / issuance | -4.87B | -1.41B | -368.00M | -2.20B | -1.46B | -33.00M | -1.80B | -3.25B |
| Ending cash balance | 2.85B | 2.35B | 4.63B | 4.56B | 3.66B | 5.93B | 5.60B | 5.24B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | -954.00M | 1.76B | 1.58B | 574.00M | 986.00M | 486.00M |
| Depreciation & amortization | 290.00M | 298.00M | 430.00M | 326.00M | 335.00M | 336.00M |
| Free cash flow | -1.16B | 1.54B | 1.34B | 349.00M | 763.00M | 230.00M |
| Dividends paid | -390.00M | -389.00M | -387.00M | -412.00M | -401.00M | -403.00M |
| Stock buybacks / issuance | -953.00M | -472.00M | -552.00M | -2.00B | -994.00M | -232.00M |
| Ending cash balance | 3.71B | 4.67B | 5.24B | 3.73B | 2.96B | 4.84B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 50.09 | 46.02 | 46.96 | 42.42 | 38.81 | -71.64 | 96.50 | 76.08 |
| ROA %i | 14.36 | 11.26 | 11.70 | 12.54 | 12.35 | -14.42 | 9.23 | 8.38 |
| ROIC %i | 22.23 | 17.43 | 18.09 | 19.10 | 18.89 | -24.41 | 24.46 | 21.80 |
| 5-year avg ROE %i | 42.56 | 45.18 | 46.81 | 45.99 | 44.87 | 20.52 | 30.73 | 36.43 |
| EBIT margin %i | 22.43 | 19.17 | 22.50 | 21.76 | 20.02 | -26.76 | 24.46 | 20.68 |
| FCF / sales %i | 14.84 | 16.71 | 20.54 | 16.55 | 11.22 | 15.50 | 2.60 | 5.60 |
| Current ratioi | 1.89 | 1.41 | 1.89 | 1.70 | 1.54 | 1.07 | 1.41 | 1.71 |
| Quick ratioi | 1.15 | 0.80 | 1.24 | 1.06 | 0.90 | 0.62 | 0.97 | 0.99 |
| Debt / assetsi | 40.27 | 47.65 | 41.72 | 38.90 | 36.28 | 33.12 | 32.72 | 33.40 |
| LT debt / equityi | 137.67 | 181.22 | 145.26 | 111.26 | 99.55 | 283.17 | 289.56 | 232.50 |
| Interest coveragei | 21.00 | 13.75 | 13.69 | 15.76 | 14.84 | -9.28 | 5.05 | 5.45 |
| Revenue CAGR (3Y) %i | 2.67 | 2.20 | 0.55 | 2.57 | -6.63 | -8.56 | -11.42 | -1.57 |
| Net income CAGR (3Y) %i | 3.44 | -3.65 | 3.90 | 3.44 | 8.55 | -- | -11.01 | -17.45 |
| FCF CAGR (3Y) %i | -0.66 | 0.81 | 10.75 | 6.37 | -10.57 | -8.50 | -52.23 | -28.64 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 96.00 | 73.38 | 76.08 | 72.14 | 82.77 | 80.78 |
| ROA %i | 9.68 | 8.67 | 8.38 | 7.39 | 8.22 | 9.17 |
| ROIC %i | 25.27 | 21.90 | 21.80 | 19.26 | 21.03 | 22.10 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 23.61 | 20.91 | 20.68 | 18.43 | 18.96 | 20.92 |
| FCF / sales %i | -- | 6.40 | 5.60 | 8.23 | 15.83 | 10.60 |
| Current ratioi | 1.72 | 1.84 | 1.71 | 1.59 | 1.24 | 1.41 |
| Quick ratioi | 1.02 | 1.03 | 0.99 | 0.88 | 0.64 | 0.78 |
| Debt / assetsi | 36.13 | 34.98 | 33.40 | 35.43 | 35.94 | 37.94 |
| LT debt / equityi | 300.16 | 264.33 | 232.50 | 334.23 | 369.38 | 304.29 |
| Interest coveragei | 5.69 | 5.32 | 5.45 | 5.10 | 5.49 | 6.18 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Quote time 2026-11-20 19:33:20 · For reference only, not investment advice and not tailored to your situation.
3M discussion 0 comments